Evidence map›Paper›PMID 27347353›Full record

ArticleAmerican journal of translational research2016

Bioinformatics investigation of therapeutic mechanisms of Xuesaitong capsule treating ischemic cerebrovascular rat model with comparative transcriptome analysis.

Jiangquan Liao, Benjun Wei, Hengwen Chen, Yongmei Liu, Jie Wang

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Effects of Xuesaitong on the Pharmacokinetics of Losartan: AnEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jiangquan LiaoGuang'anmen Hospital, China Academy of Chinese Medical SciencesNo. 5 Beixiange Street, Xicheng District, Beijing 100053, China; Graduate School, Beijing University of Chinese MedicineNo. 11 Beisanhuan East Road, Chaoyang District, Beijing 100029, China.
Benjun WeiHubei University of Chinese Medicine No. 1 Huangjiahu West Road, Hongshan District, Wuhan 430065, China.
Hengwen ChenGuang'anmen Hospital, China Academy of Chinese Medical Sciences No. 5 Beixiange Street, Xicheng District, Beijing 100053, China.
Yongmei LiuGuang'anmen Hospital, China Academy of Chinese Medical Sciences No. 5 Beixiange Street, Xicheng District, Beijing 100053, China.
Jie WangGuang'anmen Hospital, China Academy of Chinese Medical Sciences No. 5 Beixiange Street, Xicheng District, Beijing 100053, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNHubei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundXuesaitong soft capsule (XST) which consists of panax notoginseng saponin (PNS) has been used to treat ischemic cerebrovascular diseases in China. The therapeutic mechanism of XST has not been elucidated yet from prospective of genomics and bioinformatics.

methodsA transcriptome analysis was performed to review series concerning middle cerebral artery occlusion (MCAO) rat model and XST intervention after MCAO from Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were compared between blank group and model group, model group and XST group. Functional enrichment and pathway analysis were performed. Protein-Protein interaction network was constructed. The overlapping genes from two DEGs sets were screened out and profound analysis was performed.

resultsTwo series including 22 samples were obtained. 870 DEGs were identified between blank group and model group, and 1189 DEGs were identified between model group and XST group. GO terms and KEGG pathways of MCAO and XST intervention were significantly enriched. PPI networks were constructed to demonstrate the gene-gene interactions. The overlapping genes from two DEGs sets were highlighted. ANTXR2, FHL3, PRCP, TYROBP, TAF9B, FGFR2, BCL11B, RB1CC1 and MBNL2 were the pivotal genes and possible action sites of XST therapeutic mechanisms.

conclusionMCAO is a pathological process with multiple.

Indexed as

bioinformaticsMiddle cerebral artery occlusionTraditional Chinese medicinetranscriptome analysisXuesaitong capsule

Identifiers

PMID27347353
PMCPMC4891458
OpenAlexW2486998817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.